US2020277664A1PendingUtilityA1
Methods for determining a location of a biological analyte in a biological sample
Est. expiryDec 10, 2038(~12.4 yrs left)· nominal 20-yr term from priority
Inventors:Lucas Frenz
C12Q 2600/158G01N 2035/00752G01N 35/00732G01N 21/6458G01N 33/4833C12N 15/1065C12Q 1/6855C12Q 1/6881C12Q 1/6874C12Q 1/6837C12Q 1/6869B01L 2300/0829B01L 9/523B01L 3/545B01L 3/50853G02B 21/16G01N 2021/6439C12Q 2525/179C12Q 2565/60C12Q 2565/537C12Q 2543/101C12Q 2527/156C12Q 2525/161C12Q 1/6844C12Q 2563/149C12Q 1/6876C12Q 1/6841G02B 21/26G02B 21/34G02B 21/365
71
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided herein are methods of determining a location of a biological analyte in a biological sample.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for determining a location of an analyte within a region of interest in a biological sample, the method comprising:
(a) contacting a cell labelling agent with the biological sample, wherein the cell labeling agent binds specifically to the analyte and comprises a molecular tag barcode; (b) contacting the biological sample with a substrate, wherein the substrate comprises a plurality of capture probes, wherein a capture probe comprises a capture domain that specifically binds the molecular tag barcode or a portion thereof; (c) identifying the region of interest within the biological sample; and (d) detecting the presence of the molecular tag barcode within the region of interest, thereby determining the location of the analyte within the biological sample.
2 . The method of claim 1 , wherein the molecular tag barcode further comprises a cleavage domain.
3 . The method of claim 2 , wherein the cleavage domain is cleavable by at least one of light, a chemical molecule, and an enzyme.
4 . The method of claim 2 , wherein the cleavage domain is cleaved by photolysis.
5 . The method of claim 1 , wherein the analyte comprises RNA.
6 . The method of claim 1 , wherein the analyte comprises DNA.
7 . The method of claim 1 , wherein the analyte comprises a protein.
8 . The method of claim 1 , wherein the analyte comprises a cell surface analyte, an intracellular analyte, an extracellular analyte, or combinations thereof.
9 . The method of claim 1 , wherein the cell labelling agent comprises an antibody or an antigen-binding fragment thereof.
10 . The method of claim 1 , wherein the cell labelling agent comprises a lipophilic molecule.
11 . The method of claim 1 , wherein the capture domain hybridizes to the molecular tag barcode or a portion thereof.
12 . The method of claim 11 , wherein the molecular tag barcode identifies the cell labelling agent.
13 . The method of claim 1 , wherein an electric field is applied to the biological sample and the substrate.
14 . The method of claim 1 , further comprising, prior to step (d), removing the biological sample from the substrate.
15 . The method of claim 1 , wherein the biological sample is treated with a permeabilization reagent prior to or after contacting the substrate with the biological sample.
16 . The method of claim 1 , wherein the plurality of capture probes comprise identical capture domains.
17 . The method of claim 1 , wherein the plurality of capture probes comprise two or more non-identical capture domains.
18 . The method of claim 1 , wherein the plurality of capture probes are directly attached to the substrate.
19 . The method of claim 1 , wherein the plurality of capture probes are indirectly attached to the substrate.
20 . The method of claim 19 , wherein one or more features are attached to the substrate.
21 . The method of claim 20 , wherein the plurality of capture probes are attached to the one or more features.
22 . The method of claim 20 , wherein the one or more features comprises a bead.
23 . The method of claim 22 , wherein the bead is a gel bead.
24 . The method of claim 1 , wherein the detecting in step (d) comprises performing sequencing on the substrate.
25 . The method of claim 24 , wherein the sequencing on the substrate comprises one or more cycles of hybridization with labelled probes.
26 . The method of claim 25 , wherein the labelled probes are labelled with at least one of a fluorescent molecule, a fluorescent protein, a radioactive molecule, or an enzyme.
27 . The method of claim 1 , wherein the capture domain comprises an oligo(dT) sequence.
28 . The method of claim 27 , wherein the capture domain hybridizes to a poly(A) sequence of an mRNA, the molecular tag barcode or a portion thereof, or both.
29 . The method of claim 1 , wherein the substrate is located in a flow cell and a set of fluorescent probes are hybridized to the molecular tag barcode.
30 . The method of claim 29 , wherein the set of fluorescent probes are imaged, the substrate is heated, and the set of fluorescent probes are washed out of the flow cell.Join the waitlist — get patent alerts
Track US2020277664A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.